The Incredible Healing Properties of Rapamycin and the Plans Mikhail Blagosklonny has For Oncology

Rapamycin is a drug commonly used to prevent rejection of organ transplant by the body. The drug is also known as Sirolimus, and it is used to coat coronary stents and rare lung disease treatment. Rapamycin is marketed as Rapamune and is mostly referred to as the cancer drug. Sirolimus was first isolated in 1972 […]

Eric Lefkofsky Eradicating Bottlenecks in Curing Cancer

Keeping in mind the end goal to treat disease effectively, specialists require information—yet they require information around a few things. What’s more, that is what’s absent from the present therapeutic research framework, as indicated by Eric Lefkofsky, prime supporter and CEO of Tempus, a startup expecting to set up databases to calibrate disease treatment. There’s […]

Oncotarget Stays on Target

Oncotarget is the way some cells function while they undergo the aging process or combat ailments such as cancerous conditions. Moreover, it refers to a scientific understanding of this phenomenon. Lastly, is a publication hub for scholarly research articles. Because these subjects encompass such a wide scope, any organization that seeks to contribute or pioneer […]